title: First report of heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) causing fatal infection in Hungary.
authors.forename: A
authors.initials: A
authors.lastname: Tóth
authors.forename: Gy
authors.initials: G
authors.lastname: Kispál
authors.forename: E
authors.initials: E
authors.lastname: Ungvári
authors.forename: M
authors.initials: M
authors.lastname: Violka
authors.forename: Z
authors.initials: Z
authors.lastname: Szeberin
authors.forename: J
authors.initials: J
authors.lastname: Pászti
authors.forename: K
authors.initials: K
authors.lastname: Molnár
authors.forename: M
authors.initials: M
authors.lastname: Gacs
authors.forename: M
authors.initials: M
authors.lastname: Füzi
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D006348:Cardiac Surgical Procedures / Q000009:adverse effects; D055499:Catheter-Related Infections / Q000188:drug therapy / Q000382:microbiology; D019008:Drug Resistance, Neoplasm; D017809:Fatal Outcome; D006801:Humans; D006814:Hungary; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects / Q000235:genetics* / Q000302:isolation & purification; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011023:Pneumonia, Staphylococcal / Q000188:drug therapy / Q000382:microbiology*; D011183:Postoperative Complications / Q000188:drug therapy / Q000382:microbiology; D014640:Vancomycin / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin